In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi

G. M. González; D. A. Sutton; E. Thompson; R. Tijerina; M. G. Rinaldi

doi:10.1128/AAC.45.2.633-635.2001

In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi

G. M. González, D. A. Sutton, E. Thompson, R. Tijerina, M. G. Rinaldi

Pathology

Research output: Contribution to journal › Article

55 Scopus citations

Abstract

The in vitro activity of amphotericin B, fluconazole, flucytosine, itraconazole, voriconazole, and posaconazole was evaluated against 44 clinical isolates of filamentous basidiomycetous fungi. No statistically significant differences were noted between Schizophyllum commune (n = 5), Coprinus species (n = 8), Bjerkandera adusta (n = 14), and sterile, uncharacterized basidiomycetes (n = 17).

Original language	English (US)
Pages (from-to)	633-635
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	45
Issue number	2
DOIs	https://doi.org/10.1128/AAC.45.2.633-635.2001
State	Published - Feb 8 2001

Fingerprint

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Cite this

González, G. M., Sutton, D. A., Thompson, E., Tijerina, R., & Rinaldi, M. G. (2001). In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi. Antimicrobial agents and chemotherapy, 45(2), 633-635. https://doi.org/10.1128/AAC.45.2.633-635.2001

@article{ad73ef058f5b41ddad4ae12556d89efc,

title = "In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi",

abstract = "The in vitro activity of amphotericin B, fluconazole, flucytosine, itraconazole, voriconazole, and posaconazole was evaluated against 44 clinical isolates of filamentous basidiomycetous fungi. No statistically significant differences were noted between Schizophyllum commune (n = 5), Coprinus species (n = 8), Bjerkandera adusta (n = 14), and sterile, uncharacterized basidiomycetes (n = 17).",

author = "Gonz{\'a}lez, {G. M.} and Sutton, {D. A.} and E. Thompson and R. Tijerina and Rinaldi, {M. G.}",

year = "2001",

month = feb,

day = "8",

doi = "10.1128/AAC.45.2.633-635.2001",

language = "English (US)",

volume = "45",

pages = "633--635",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of basidiomycetous fungi

AU - González, G. M.

AU - Sutton, D. A.

AU - Thompson, E.

AU - Tijerina, R.

AU - Rinaldi, M. G.

PY - 2001/2/8

Y1 - 2001/2/8

N2 - The in vitro activity of amphotericin B, fluconazole, flucytosine, itraconazole, voriconazole, and posaconazole was evaluated against 44 clinical isolates of filamentous basidiomycetous fungi. No statistically significant differences were noted between Schizophyllum commune (n = 5), Coprinus species (n = 8), Bjerkandera adusta (n = 14), and sterile, uncharacterized basidiomycetes (n = 17).

AB - The in vitro activity of amphotericin B, fluconazole, flucytosine, itraconazole, voriconazole, and posaconazole was evaluated against 44 clinical isolates of filamentous basidiomycetous fungi. No statistically significant differences were noted between Schizophyllum commune (n = 5), Coprinus species (n = 8), Bjerkandera adusta (n = 14), and sterile, uncharacterized basidiomycetes (n = 17).

UR - http://www.scopus.com/inward/record.url?scp=0035139563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035139563&partnerID=8YFLogxK

U2 - 10.1128/AAC.45.2.633-635.2001

DO - 10.1128/AAC.45.2.633-635.2001

M3 - Article

C2 - 11158771

AN - SCOPUS:0035139563

VL - 45

SP - 633

EP - 635

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 2

ER -

Access to Document

10.1128/AAC.45.2.633-635.2001